alternatives to glp 1 meds MedVi 2026: Pricing & Competitors Dr Sarah Barenbaum shares FDA-approved

Weill Professor of Metabolic Research at Weill Cornell

GLP-1 specifically binds to the glucagon-like peptide-1 receptor (GLP-1R) in the body, directly stimulating the secretion of insulin by pancreatic -cells, promoting proliferation and differentiation, and inhibiting cell apoptosis, thereby exerting a glycemic lowering effect

HCP, healthcare provider

Some of the inconsistency across preclinical reports reflects differences in the compounds, doses, and assay conditions used, so standardised reporting of peptide characterisation and experimental conditions would make the literature easier to interpret and to replicate

Participants who combined liraglutide (3.0 mg) with supervised exercise maintained at least 10% weight loss one year after stopping all treatments